Healthcare Realty Trust Incorporated (HR) is a real estate investment trust (REIT) — a company that owns income-producing property and passes most of its taxable income to shareholders as dividends. It is the first and largest REIT to specialize almost exclusively in medical outpatient buildings, the facilities clustered around hospital campuses that host clinics, surgery centers, and physician practices. The company owns hundreds of properties across dozens of U.S. states, generating rent through long-term leases with health systems and physician groups.
The $24 mark has entered the conversation because it sits at the top of the current analyst range. According to aggregated data from Finviz and Barron's, Wall Street's highest 12-month price target for HR is $24, while the average target sits near $21.58 and the low stands around $18. With the stock trading in the low-$19 range, $24 represents a meaningful — but not extreme — move of roughly 24%, well above the stock's recent 52-week high near $22.
HR has recovered considerably from its 52-week low near $16 but remains below the 52-week high of about $22. The stock carries a dividend yield above 5%, backed by a quarterly payout of $0.24 per share. However, the company has reported negative earnings per share on a trailing basis, reflecting impairment charges and the costs of repositioning its portfolio, which is why the stock trades without a conventional price-to-earnings ratio.
The core bull case is demographic and structural. The U.S. population is aging, and healthcare delivery is steadily shifting from expensive inpatient hospital stays toward lower-cost outpatient settings — precisely the facilities HR owns. Recent results have shown encouraging operating trends, including same-store net operating income growth and occupancy above 90%, alongside strong tenant retention. Management has also pursued a strategic reset through asset sales, a joint venture with private-equity firm KKR & Co. (KKR), and share repurchases aimed at narrowing the gap between the public stock price and private-market valuations of medical office buildings. If these initiatives translate into rising funds from operations and a clearer path to earnings growth, the stock could reasonably challenge new highs.
Several factors work against a swift run to $24. As a REIT, HR is sensitive to interest rates: higher borrowing costs raise the discount rate applied to future cash flows and make the dividend less competitive against risk-free yields. The company also carries meaningful leverage, and its recent history of net losses means earnings-based valuation support is thin. A downturn in healthcare demand, tenant financial stress, or slower-than-expected leasing could stall occupancy gains and weigh on the share price.
The analyst community is constructive but cautious. The consensus rating on HR leans toward Buy or Overweight, yet the distribution of targets — from about $18 at the low end to $24 at the high end — reflects genuine disagreement about how quickly the turnaround will materialize. Several firms have raised their targets over the past year as fundamentals improved, but many maintain Hold-equivalent ratings, signaling that the market wants more evidence of sustained earnings growth before paying up for the shares.
From a technical perspective, $24 is also a round-number psychological level that sits just above the prior high, meaning the stock must first clear the $22 zone before $24 comes into focus. Support appears near the $18 level, with the 52-week low near $16 representing a deeper floor. The $20 area acts as a natural intermediate resistance zone where the stock has spent time consolidating. A decisive move through $22 on strong volume would mark an important breakout and put the $24 target within realistic reach.
Traders monitoring HR can complement their own research with tools like Tickeron's AI Daily Buy/Sell Signals. This product uses artificial intelligence to continuously scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. By surfacing changing trends and potential opportunities in real time, the signals help traders monitor existing positions and identify setups more efficiently than manual screening alone. Investors tracking whether HR can build momentum toward higher levels may find these automated signals a useful addition to their decision-making process.
Can HR reach $24? The level is not out of reach, but it is also not a foregone conclusion. The strongest argument for the move is the combination of favorable demographics, improving operating fundamentals, and a strategic repositioning that could narrow the valuation gap to private-market real estate. The primary counterweights are interest-rate sensitivity, persistent losses, and leverage. For $24 to become reality, investors would likely need to see several quarters of consistent same-store growth, stabilizing or improving funds from operations, and broader market willingness to pay a richer multiple for healthcare REITs. Clearing the prior $22 high would be the first meaningful confirmation. Until then, $24 should be viewed as a credible longer-term objective rather than a near-term certainty.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, HR has been closely correlated with FRT. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if HR jumps, then FRT could also see price increases.
| Ticker / NAME | Correlation To HR | 1D Price Change % |
|---|---|---|
| HR | 100% | +0.11% |
| HR (2 stocks) | 63% Loosely correlated | -0.16% |
| Publishing: Books/Magazines (19 stocks) | 58% Loosely correlated | -0.62% |
| Consumer Services (221 stocks) | 14% Poorly correlated | +0.44% |